Loading...
InfuSystem Holdings, Inc.
INFU•AMEX
Healthcare
Medical - Instruments & Supplies
$6.01
$0.10(1.69%)
InfuSystem Holdings, Inc. (INFU) Financial Performance & Income Statement Overview
Review InfuSystem Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.22%
↑ 7.22%
Operating Income Growth
68.57%
↑ 68.57%
Net Income Growth
168.92%
↑ 168.92%
Operating Cash Flow Growth
82.30%
↑ 82.30%
Operating Margin
6.07%
↑ 6.07%
Gross Margin
52.73%
↑ 52.73%
Net Profit Margin
3.07%
↑ 3.07%
ROE
7.63%
↑ 7.63%
ROIC
9.46%
↑ 9.46%
InfuSystem Holdings, Inc. (INFU) Income Statement & Financial Overview
Review InfuSystem Holdings, Inc.'s (INFU) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $33.85M | $35.32M | $33.70M | $32.00M |
| Cost of Revenue | $15.63M | $16.27M | $17.58M | $16.07M |
| Gross Profit | $18.22M | $19.05M | $16.12M | $15.93M |
| Gross Profit Ratio | $0.54 | $0.54 | $0.48 | $0.50 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $15.35M | $15.78M | $14.27M | $16.77M |
| Operating Expenses | $15.60M | $15.78M | $14.27M | $16.77M |
| Total Costs & Expenses | $31.23M | $32.05M | $31.84M | $32.84M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $361000.00 | $476000.00 | $484000.00 | $456000.00 |
| Depreciation & Amortization | -$9000.00 | $3.15M | $3.03M | $2.90M |
| EBITDA | $2.62M | $6.41M | $4.89M | $2.06M |
| EBITDA Ratio | $0.08 | $0.18 | $0.15 | $0.06 |
| Operating Income | $2.62M | $3.27M | $1.85M | -$845000.00 |
| Operating Income Ratio | $0.08 | $0.09 | $0.06 | -$0.03 |
| Other Income/Expenses (Net) | -$352000.00 | -$480000.00 | -$547000.00 | -$453000.00 |
| Income Before Tax | $2.26M | $2.79M | $1.31M | -$1.30M |
| Income Before Tax Ratio | $0.07 | $0.08 | $0.04 | -$0.04 |
| Income Tax Expense | $1.33M | -$1.79M | $591000.00 | -$186000.00 |
| Net Income | $933000.00 | $1.81M | $717000.00 | -$1.11M |
| Net Income Ratio | $0.03 | $0.05 | $0.02 | -$0.03 |
| EPS | $0.04 | $0.08 | $0.03 | -$0.05 |
| Diluted EPS | $0.04 | $0.08 | $0.03 | -$0.05 |
| Weighted Avg Shares Outstanding | $21.27M | $21.29M | $21.30M | $21.23M |
| Weighted Avg Shares Outstanding (Diluted) | $21.74M | $21.71M | $21.71M | $21.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan